All News

The results of a recent UK study reveal that psychological distress, whether considered low or moderate, can increase a patient’s risk for chronic obstructive pulmonary disease (COPD), arthritis, and cardiovascular disease (CVD).

As health care providers work to combat the growing abuse epidemic, the results of a new study suggest that interventions using behavioral insights can change the course of care.

In response to the CMS’ step therapy approach to lowering drug costs, many advocacy groups expressed concern that the move will harm patient access to treatments for chronic conditions.

Higher-than-recommended physical activity levels can help older adults avoid chronic diseases, disability, and cognitive decline for longer.

Top news of the day from across the health care landscape.

This action, aimed at saving patients money, is part of the Trump administration’s larger agenda to create competition among medications that treat the same conditions.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

A protein that regulates the formation of myelin sheaths may lead to new treatments for multiple sclerosis.

American Medical Association urges the Department of Justice to block merger between CVS Health and Aetna due to concerns over anticompetitive practices in health care market.

The program recognizes over 30 exceptional pharmacy professionals in 10 categories.

The FDA has approved several strengths of Apotex Inc.’s potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy (CGT) designation

Drug costs in the United States are not consistently associated with their value or net health benefits.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Study offers insight into the evolution of global dissemination of hepatitis B virus genotypes D and A.

The FDA has approved updates to the labeling for hepatitis C virus (HCV) drug glecaprevir and pibrentasvir (Mavyret) to include new data from 2 clinical studies.

Officials with the FDA have approved a new treatment for 2 rare types of non-Hodgkin lymphoma of the skin.

The revised labeling for glecaprevir and pibrentasvir (Mavyret) includes data from clinical trials on the safety and efficacy of the treatment for HIV-1 coinfected patients and liver and kidney transplant recipients.

The FDA has approved several strengths of Apotex Inc.’s potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy designation.

Officials with the FDA have approved a new treatment for 2 rare types of non-Hodgkin lymphoma of the skin, relapsed or refractory mycosis fungoides and Sézary syndrome, after at least 1 prior systemic therapy.

Mogamulizumab-kpkc (Poteligeo, Kyowa Kirin) injection is indicated to treat adult patients with 2 types of non-Hodgkin lymphoma: relapsed or refractory mycosis fungoides or Sézary syndrome.

New formulation of gene-silencing drug may effectively treat amyotrophic lateral sclerosis.

A blood-based test to assess tumor mutational burden was recently discovered as being able to accurately identify patients with non–small cell lung cancer (NSCLC) who could benefit from checkpoint inhibitor treatment.

A healthy diet that includes physical activity and discourages alcohol consumption can significantly reduce overall cancer risk, as well as lower breast, prostate, and colorectal cancer risk.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.